Skip to content

Fluoride-labeled boronophenylalanine PET imaging in patients solid tumors

Fluoride-labeled boronophenylalanine PET imaging in patients solid tumors

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200063509
Enrollment
Unknown
Registered
2022-09-09
Start date
2022-09-09
Completion date
Unknown
Last updated
2023-04-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

solid tumors

Interventions

Sponsors

Department of Nuclear Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Age <80 years old, ECOG score is 0-2; 2. Patients with clinically diagnosed solid tumors, including but not limited to recurrent head and neck cancer, glioma, pancreatic cancer, osteosarcoma, etc.; 3. The selected subjects need to sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Pregnant women; 2. Age >= 80 years old; 3. renal failure (serum Cr>3mg/dl); 4. Patients with claustrophobia; 5. other reasons.

Design outcomes

Primary

MeasureTime frame
TNR;

Countries

China

Contacts

Public ContactXiaohua Zhu

Tongji Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology

evazhu@vip.sina.com+86 13971513770

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026